|
|
|
Volumn 63, Issue 21, 1998, Pages 5233-5254
|
|
Financial disclosure by clinical investigators--FDA. Final rule.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CONFLICT OF INTEREST;
DRUG APPROVAL;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
LEGAL APPROACH;
LEGAL ASPECT;
PERSONNEL;
SAFETY;
STANDARD;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
LEGAL APPROACH;
CONFLICT OF INTEREST;
DEVICE APPROVAL;
DRUG APPROVAL;
FINANCIAL SUPPORT;
RESEARCH PERSONNEL;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0032472457
PISSN: 00976326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|